Store

Home | Store | The Market for Contract Manufacturing in IVD, 2022

The Market for Contract Manufacturing in IVD, 2022

Publication Date: September 2, 2022

LICENSE

Clear

SKU: 22-706

Tags: Coagulation, Contract Research and Manufacturing Orgs, COVID-19, Diagnostic Instruments, Genetic Diseases, Hematology, Histology and Cytology, Immunoassay, In Vitro Diagnostics (IVD), Infectious Diseases, Molecular Diagnostics, Oncology and Cancer, Point-of-Care (POC) Testing

Pages: 140

SKU: 22-706

The Market for Contract Manufacturing in In Vitro Diagnostics (IVD), 2022 provides valuable insights into the global in vitro diagnostic (IVD) industry’s contract manufacturing segment, covering market size, trends, and competitive analysis.

Report Highlights:

Market Overview:
- Detailed examination of the multi-billion-dollar contract manufacturing segment within the IVD industry.
- Analysis of how leading worldwide producers of proprietary IVD systems are increasingly relying on outside contractors to:
  - Expand existing product lines
  - Broaden access to IVD testing technologies
  - Increase manufacturing capacity without capital investment
  - Quickly introduce tests and systems for emerging diseases (e.g., COVID-19, Monkeypox)
  - Gain support for regulatory filings
  - Penetrate high-growth applications, especially in point-of-care (POC) testing
  - Meet specialized testing needs of major end users
Benefits for New and Smaller IVD Producers:
- Discussion on how contract manufacturing enables new and smaller IVD producers to build up product lines and enhance competitiveness in the market.
- Exploration of the segment’s role as a major source of private label tests, instruments, and accessories sold by medical supply distributors, home healthcare outlets, and drug stores.
- Analysis of the expansion in private label applications, largely influenced by the COVID-19 pandemic.

Scope and Methodology:

Technology Segmentation:
- In-depth analysis of contract IVD manufacturing by technology, including immunoassay, clinical chemistry, molecular assays, microbiology, hematology, histology/cytology, coagulation, blood grouping, and other technologies.
Product Segmentation:
- Detailed segmentation by product, covering reagents and test kits, instruments and systems, and accessories.
End-Use Applications:
- Examination of contract IVD manufacturing by end-use applications, focusing on point-of-care and clinical laboratory testing.
Non-Manufacturing Services:
- Discussion on contract IVD services in non-manufacturing areas such as assay development, instrument design, regulatory filings, and packaging.

Market Insights:

Principal Customers:
- Analysis of principal customers for contract IVD manufacturing and non-manufacturing services, including traditional IVD product producers, medical supply distributors, drug stores, mass merchandisers, and internet and mail-order enterprises.
Revenue Estimates:
- Global revenue estimates for the year 2021 and forecasts for each year from 2022 to 2026, expressed in current US dollars.

For further details and to purchase directly, please contact us.

Table: Global IVD Demand, by Product Group, 2021-2026 (million dollars)

Product Group	2021	2022	2023	2024	2025	2026	CAGR
Reagents & Test Kits:	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Clinical Laboratory	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Point-of-Care	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Instruments & Systems:	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Clinical Laboratory	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Point-of-Care	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Supplies & Accessories:	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Clinical Laboratory	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Point-of-Care	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Global Total	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Clinical Laboratory	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%
Point-of-Care	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	$XX Million	XX%

Source: Kalorama Information

For further details and to purchase directly, please contact us.

Chapter 1: Executive Summary

Global Market Outlook – Contract IVD Manufacturing

Table 1-1: Summary Table – Global Contract IVD Manufacturing Market, 2021-2026 (million dollars)

Scope and Methodology

Chapter 2: Market Environment

Overview

Global Economic Outlook

Table 2-1: Gross Domestic Product by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (billion dollars)

Per Capita Gross Domestic Product

Table 2-2: Per Capita Gross Domestic Product by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (dollars)

Population

Table 2-3: Population by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million persons)

Age Distribution

Population 50 Years & Older

Table 2-4: Population 50 Years & Older by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million persons)
Table 2-5: Percentage of Population 50 Years & Older by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million persons)

Population 65 Years & Older

Table 2-6: Population 65 Years & Older by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million persons)
Table 2-7: Percentage of Population 65 Years & Older by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million persons)

Global Healthcare Trends

Medical Conditions

Health Expenditures

Table 2-8: Health Expenditures by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (billion dollars)
Table 2-9: Per Capita Health Expenditures by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (dollars)

Hospital Beds

Table 2-10: Number of Hospital Beds by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (thousands)
Table 2-11: Number of Hospital Beds Per 1,000 Capita by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026

Physicians

Table 2-12: Number of Practicing Physicians by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (thousands)
Table 2-13: Number of Practicing Physicians Per 1,000 Capita by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026

Patient Activity

Acute Care Hospital Admissions

Table 2-14: Number of Acute Care Hospital Admissions by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (thousands)
Table 2-15: Number of Acute Care Hospital Admissions Per 1,000 Capita by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026

Surgical Procedures

Table 2-16: Number of Surgical Procedures by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (thousands)
Table 2-17: Number of Surgical Procedures Per 1,000 Capita by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026

Physicians’ Consultations

Table 2-18: Number of Physicians’ Consultations by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (millions)
Table 2-19: Number of Physicians’ Consultations Per Capita by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026

IVD Tests

Table 2-20: Number of IVD Tests by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (millions)
Table 2-21: Number of IVD Tests Per Capita by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026

Chapter 3: IVD Products

Industry Overview

Table 3-1: Global IVD Product Demand by Technology (Immunoassay, Clinical Chemistry, Molecular, Microbiology, Hematology, Coagulation, Histology/Cytology, and Blood Grouping), 2021-2026 (million dollars)

IVD Product Demand by Technology

Immunoassays

Clinical Chemistry

Molecular IVD Technology

Microbiology

Hematology

Coagulation

Histology/Cytology

Blood Grouping

Other IVD Technologies

Product Groups

Table 3-2: Global IVD Demand by Product Group (Reagents & Test Kits, Instruments & Systems, Supplies & Accessories), 2021-2026 (million dollars)

IVD Reagents & Test Kits

Table 3-3: Global IVD Reagents & Test Kits Demand by Technology (Point-of-Care, Clinical Laboratory, Immunoassay, Clinical Chemistry, Molecular, Microbiology, Hematology, Coagulation, Histology/Cytology, and Blood Grouping), 2021-2026 (million dollars)

IVD Instruments & Systems

Table 3-4: Global IVD Instruments & Systems Demand by Technology (Point-of-Care, Clinical Laboratory, Immunoassay, Clinical Chemistry, Molecular, Microbiology, Hematology, Coagulation, Histology/Cytology, and Blood Grouping), 2021-2026 (million dollars)

IVD Supplies & Accessories

Table 3-5: Global IVD Supplies & Accessories Demand by Technology (Point-of-Care, Clinical Laboratory, Immunoassay, Clinical Chemistry, Molecular, Microbiology, Hematology, Coagulation, Histology/Cytology, and Blood Grouping), 2021-2026 (million dollars)

Production by Region

Table 3-6: Global IVD Production Value by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million dollars)

Chapter 4: Contract IVD Manufacturing

Market Overview

Market Forecast

Table 4-1: Global Contract IVD Manufacturing Demand by Technology (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million dollars)

Regional Trends

Table 4-2: Global Contract IVD Manufacturing Demand by Country/Region (North America, Western Europe, Asia/Pacific, Central & South America, Eastern Europe, and Africa/Middle East), 2021-2026 (million dollars)

Product Groups

Table 4-3: Global Contract IVD Manufacturing Demand by Product Group (Reagents & Test Kits, Instruments & Systems, and Supplies & Accessories), 2021-2026 (million dollars)

Contract Immunoassay Products

Overview

Types of Immunoassays

Contract Manufacturing Opportunities